Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells

Abstract

We have previously shown that the toxic pro-oxidant methylselenol is released from selenomethionine (SeMET) by cancer cells transformed with the adenoviral methionine α,γ-lyase (methioninase, MET) gene cloned from Pseudomonas putida. Methylselenol damaged the mitochondria via oxidative stress, and caused cytochrome c release into the cytosol thereby activating caspase enzymes and thereby apoptosis. However, gene therapy strategies are less effective if tumor cells overexpress the antiapoptotic mitochondrial protein bcl-2. In this study, we investigated whether rAdMET/SeMET was effective against bcl-2-overproducing A549 lung cancer cells. We established two clones of the human lung cancer A549 cell line that show moderate and high expression levels of bcl-2, respectively, compared to the parent cell line, which has very low bcl-2 expression. Staurosporine-induced apoptosis was inhibited in the bcl-2-overproducing clones as well as in the parental cell line. In contrast to staurosporine, apoptosis was induced in the bcl-2-overproducing clones as well as the parental cell line by AdMET/SeMET. Apoptosis in the rAdMET–SeMET-treated cells was determined by fragmentation of nuclei, and release of cytochrome c from mitochondria to the cytosol. A strong bystander effect of AdMET/SeMET was observed on A549 cells as well as the bcl-2-overproducing clones. rAdMET/SeMET prodrug gene therapy is therefore a promising novel strategy effective against bcl-2 overexpression, which has blocked other gene therapy strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Miki K, Xu M, Gupta A, et al. Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res. 2001;61:6805–6810.

    CAS  PubMed  Google Scholar 

  2. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ . Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281–1292.

    Article  CAS  Google Scholar 

  3. Kroemer G, Reed JC . Mitochondrial control of cell death. Nat Med. 2000;6:513–519.

    Article  CAS  Google Scholar 

  4. Costantini P, Jacotot E, Decaudin D, Kroemer G . Mitochondrion as a novel target of anticancer chemotherapy. J Nat Cancer Inst. 2000;92:1042–1053.

    Article  CAS  Google Scholar 

  5. Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 1996;184:1331–1341.

    Article  CAS  Google Scholar 

  6. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . The release of cytochrome c from mitochondria: a primary site for Bcl-2 reguration of apoptosis. Science. 1997;275:1132–1136.

    Article  CAS  Google Scholar 

  7. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129–1132.

    Article  CAS  Google Scholar 

  8. Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A . Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antobody-mediated apoptosis of human malignant glioma cells and confers to resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest. 1995;95:2633–2643.

    Article  CAS  Google Scholar 

  9. Hamel W, Magnelli L, Chiarugi VP, Israel MA . Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptosis death of bystander cells. Cancer Res. 1996;56:2697–2702.

    CAS  PubMed  Google Scholar 

  10. Carsten F, Christoph S, Barbara H, et al. Bcl-2 expression in high-grade human glioma: clinical and experimental study. J Neurooncol. 2000;48:207–216.

    Article  Google Scholar 

  11. Tu Y, Xu FH, Liu J, et al. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood. 1996;88:1805–1812.

    CAS  PubMed  Google Scholar 

  12. Elstein KH, Zucker RM . Comparison of cellular and nuclear flow cytometirc techniques for discriminating apoptotic subpopulations. Exp Cell Res. 1994;211:322–331.

    Article  CAS  Google Scholar 

  13. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med. 1999;189:381–394.

    Article  CAS  Google Scholar 

  14. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441–446.

    Article  CAS  Google Scholar 

  15. Nutt LK, Chandra J, Pataer A, et al. Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis. J. Biol Chem. 2002;277:20301–20308.

    Article  CAS  Google Scholar 

  16. Spallholz JE . On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994;17:45–64.

    Article  CAS  Google Scholar 

  17. Stewart MS, Spallholz JE, Nelder KH, Pence BC . Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999;26:42–48.

    Article  CAS  Google Scholar 

  18. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA. 1996;276:1957–1963.

    Article  CAS  Google Scholar 

  19. Chaudiere J, Courtin O, Leclaire J . Glutathione oxidase activity of selenocystamine: a mechanistic study. Arch Biochem Biophys. 1992;296:328–336.

    Article  CAS  Google Scholar 

  20. Yan L, Spallholz E . Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem Pharmacol. 1993;45: 429–437.

    CAS  PubMed  Google Scholar 

  21. Green DR, Reed JC . Mitochondria and apoptosis. Science. 1998;281:1309–1312.

    Article  CAS  Google Scholar 

  22. Cai J, Yang J, Jones DP . Mitochondrial control of apoptosis: The role of cytochrome c. Biochim Biophys Acta. 1998;1366:139–149.

    Article  CAS  Google Scholar 

  23. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf–caspase-9 complex initiates an apoptotic protease cascades. Cell. 1997;91:479–489.

    Article  CAS  Google Scholar 

  24. Thornberry NA, Lazebnik Y . Caspase: enemies within. Science. 1998;281:1312–1316.

    Article  CAS  Google Scholar 

  25. Tanaka H, Esaki N, Soda K . Properties of L-methionine γ-lyase from Pseudomonas ovalis. Biochemistry. 1977;16:100–106.

    Article  CAS  Google Scholar 

  26. Inoue H, Inagaki K, Sugimoto M, Esaki N, Soda K, Tanaka H . Structure analysis of the L-methionine γ-lyase gene from Pseudomonas putida. J Biochem. 1995;117:1120–1125.

    Article  CAS  Google Scholar 

  27. Esaki N, Tanaka H, Uemura S, Suzuki T, Soda K . Catalytic action of L-methionine gamma-lyase on selenomethionine and selenols. Biochemistry. 1979;18:407–410.

    Article  CAS  Google Scholar 

  28. Akhaven-Tafti H, et al. Clin Chem. 1995; 41:1368–1369.

  29. Iwahashi H, Eguchi Y, Yasuhara N, et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal atrophy. Nature. 1997;390:413–417.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R M Hoffman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamamoto, N., Gupta, A., Xu, M. et al. Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells. Cancer Gene Ther 10, 445–450 (2003). https://doi.org/10.1038/sj.cgt.7700587

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700587

Keywords

This article is cited by

Search

Quick links